Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

INTRODUCTION: Guidelines for the use of cerebrospinal fluid (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) establish that each laboratory must use internally qualified cutoff values. We determined the concentrations of biomarkers that discriminate cases from controls and combinat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (Amst)
Auteurs principaux: Forlenza, Orestes V., Radanovic, Marcia, Talib, Leda L., Aprahamian, Ivan, Diniz, Breno S., Zetterberg, Henrik, Gattaz, Wagner F.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2015
Sujets:
CSF Biomarkers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879480/
https://ncbi.nlm.nih.gov/pubmed/27239524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires